Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021

• Hauptverfasser: Emily D. Meyer (Verfasst von), Sandra Dudareva (Verfasst von), Christian Kollan (Verfasst von), Stefan Mauss (Verfasst von), Heiner Wedemeyer (Verfasst von), Daniel Schmidt (Verfasst von), Ruth Zimmermann (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2023-05-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Effectively treating hepatitis C viral (HCV) infections prevents sequelae and onward transmission. In Germany, HCV drug prescriptions have declined since 2015. During the COVID-19 pandemic, lockdowns impacted the access to HCV care services and HCV treatment. We assessed if the COVID-19 pandemic fur...